Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
A. Frille (Leipzig, Germany), H. Kuhn (Leipzig, Germany), C. Hänel (Leipzig, Germany), T. Ebert (Leipzig, Germany), H. Seyfarth (Leipzig, Germany), H. Wirtz (Leipzig, Germany). Cocultured brown or white adipocytes can reduce efficacy of targeted therapy in lung cancer cells. 1764

Member's Comments

No comment yet.

Related content which might interest you: The influence of non-small cell lung cancer cells on the expression of adipokines in brown adipose tissue Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 The influence of brown adipose tissue on the proliferation and chemosensitivity in non-small cell lung cancer cells Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 The effect of methylene blue in the photodynamic therapy on A549 lung cancer cell lines Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Modulation of tumor-microenvironmental factors and cancer growth in co-cultures of fresh human lung tissue and patient-derived cancer cells Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 In vitro culture of basal-like cells from fibrotic peripheral lung tissue Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Mitochondria related hormone stanniocalcin-1 (STC-1) derived from human multipotent stromal cells (MSCs) reduce cell death of human lung epithelial cell line (A549) under fetal acidosis and/or hypoxia Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Aerosolised delivery of mesenchymal stromal cells to the lungs: towards a novel therapy Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions Year: 2017 Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment Source: Eur Respir J 2002; 20: Suppl. 38, 400s Year: 2002 Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Evidence of increased pluripotent cells in adult human lung tissue derived from fibrotic lungs compared to non-fibrotic control lungs Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Circulating CD133(+) stem cells in lung cancer patients Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Localisation of endothelial progenitor cells (EPC) in NSCLC patients and sensitivity of EPC to chemotherapeutic agents in vitro Source: Eur Respir J 2004; 24: Suppl. 48, 4s Year: 2004 IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 Interactions of lung cancer with adipose and muscle tissue in the development of cancer cachexia Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 The ability of autologous dendritic cells to destroy NSCLC cells in vitro Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007